Sysmex (SSMXY) Stock Price, News & Analysis

Company Overview

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Key Stats

• Today's Range: $18.33 to $18.59
• 50-Day Range: $17.78 to $19.57
• 52-Week Range: $14.38 to $22.00
• Volume: 96,136 shs
• Average Volume: 68,856 shs
• Market Capitalization: $11.54 billion
• P/E Ratio: 36.87
• Dividend Yield: 0.65%
• Price Target: N/A
• Consensus Rating: N/A

SSMXY Stock Analysis - Frequently Asked Questions

How have SSMXY shares performed this year?

Sysmex's stock was trading at $18.28 at the beginning of 2025. Since then, SSMXY stock has increased by 0.3% and is now trading at $18.34.
View the best growth stocks for 2025 here.

How were Sysmex's earnings last quarter?

Sysmex Co. (OTCMKTS:SSMXY) issued its earnings results on Wednesday, February, 12th. The company reported $0.17 earnings per share (EPS) for the quarter.

When did Sysmex's stock split?

Sysmex's stock split on the morning of Tuesday, April 2nd 2024. The 1.5-1 split was announced on Tuesday, April 2nd 2024. The newly created shares were payable to shareholders after the market closes on Tuesday, April 2nd 2024. An investor that had 100 shares of stock prior to the split would have 150 shares after the split.

Does Sysmex have any subsidiaries?

Sysmex subsidiaries include HITADO GmbH, HYPHEN BioMed SAS, Jinan Sysmex Medical Electronics Co. Ltd., Medicaroid Corporation, PT.Sysmex Indonesia, RIKEN GENESIS CO. LTD., Sysmex America Inc., and others.

How do I buy shares of Sysmex?

Shares of SSMXY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/12/2025
• Today: 5/04/2025
• Next Earnings (Estimated): 5/08/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private households
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:SSMXY
• CIK: 1517231
• Web: www.sysmex.co.jp
• Phone: (178) 265-0500
• Fax: 817-8265-0524
• Employees: 11,012
• Year Founded: 1968

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 36.87
• Forward P/E Ratio: 32.18
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 3.19
• Quick Ratio: 2.42

Sales & Book Value

• Annual Sales: $3.20 billion
• Price / Sales: 3.61
• Cash Flow: $0.93 per share
• Price / Cash Flow: 19.81
• Book Value: $4.56 per share
• Price / Book: 4.02

Miscellaneous

• Outstanding Shares: 629,473,000
• Free Float: N/A
• Market Cap: $11.54 billion
• Optionable: Not Optionable
• Beta: 1.08